Trademark: 88482035
Status Date
Monday, July 11, 2022
Filing Date
Thursday, June 20, 2019
Published for Opposition
Tuesday, October 15, 2019
Abandoned Date
Monday, July 11, 2022
5 Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment
Jul 11, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 11, 2022
Abandonment - No Use Statement Filed
Dec 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 10, 2021
Sou Extension 4 Granted
Dec 10, 2021
Sou Extension 4 Filed
Dec 10, 2021
Teas Extension Received
Jun 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2021
Sou Extension 3 Granted
Jun 9, 2021
Sou Extension 3 Filed
Jun 9, 2021
Teas Extension Received
Dec 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2020
Sou Extension 2 Granted
Dec 7, 2020
Sou Extension 2 Filed
Dec 7, 2020
Teas Extension Received
Apr 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2020
Sou Extension 1 Granted
Apr 22, 2020
Sou Extension 1 Filed
Apr 22, 2020
Teas Extension Received
Dec 10, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 11, 2019
Approved For Pub - Principal Register
Sep 11, 2019
Assigned To Examiner
Jul 1, 2019
New Application Office Supplied Data Entered In Tram
Jun 24, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
